Matthew J.
Bobby

Mr. Bobby has advised many corporate and private equity clients, including ADT, AerCap, Afterpay, AmerisourceBergen, AngloGold Ashanti, Aras, AveXis, Axalta, BDT & MSD, British American Tobacco, Canadian National Railway, Centrica, Costamare, Crown Castle, CyrusOne, DiaSorin, FactSet, GreenSky, Hasbro, Hearst, Honeywell, IBM, Illumina, Instacart, Johnson & Johnson, Just Eat Takeaway.com, Kenvue, Light & Wonder, Lindsay Goldberg, Martin Marietta, National Grid, Neurotech, Northrop Grumman, Novartis, Olin, Owl Rock, Peugeot, RWE, SMBC Aviation Capital, Starwood Hotels, Thermo Fisher Scientific, Time Warner, US Foods, Viacom, Viatris, WestRock and White Mountains.

Mr. Bobby’s notable matters include representing:

• ADT in its pending $15.3 billion acquisition by Thrive Holdings, its $170 million acquisition of Origin AI and the $1.6 billion sale of its commercial business to GTCR;
• Instacart in its pending $17 billion acquisition by DoorDash;
• Neurotech in its $550 million acquisition by Alcon;
• IBM in its acquisition of HRL Laboratories;
• Martin Marietta in its $13.5 billion combination with Lhoist North America, its acquisition of New Frontier Materials, its exchange of certain assets with Quikrete, its acquisition of Premier Magnesia, its $2.05 billion acquisition of aggregates operations from Blue Water Industries, the $2.1 billion sale of its South Texas cement business and related concrete operations to CRH, the proposed sale of its California cement plant and related terminals, the sale of certain West Coast cement and concrete operations to CalPortland and its $2.3 billion acquisition of Lehigh West Region;
• Thermo Fisher Scientific in the $1.075 billion sale of its microbiology business to Astorg, its $20.9 billion acquisition of PPD and its $3.1 billion acquisition of Olink;
• Clearwater Analytics’ special committee in the $8.4 billion acquisition by a consortium led by Permira and Warburg Pincus;
• Axalta in its pending $25 billion merger of equals with AkzoNobel;
• Johnson & Johnson in numerous matters, including its $3.05 billion acquisition of Halda Therapeutics, its $14.6 billion acquisition of Intra‑Cellular Therapies, its $2 billion acquisition of Ambrx, the IPO and separation of Kenvue, its $16.6 billion acquisition of Abiomed, its $6.5 billion acquisition of Momenta, its $3.4 billion acquisition of Auris Health, the $2.8 billion sale of its Advanced Sterilization Products business to Fortive, the $2.1 billion sale of its LifeScan business to Platinum Equity, the $1.045 billion sale of its Codman Neurosurgery business to Integra and its $30 billion acquisition of Actelion;
• Lindsay Goldberg and its portfolio companies in connection with multiple transactions, including Amentum’s Reverse Morris Trust merger with Jacobs’ Critical Mission Solutions and Cyber and Intelligence businesses, creating a combined organization with $13 billion in revenue; the sale of Liquid Tech Solutions to Velocity Rail Solutions, a Wind Point Partners portfolio company; the acquisition of Golden State Foods; the acquisition of The Kleinfelder Group; Summit Interconnect’s acquisition of Royal Circuit Solutions; the sale of Pixelle to H.I.G. Capital; and BAF in Lindsay Goldberg’s sale of BAF to Madison IAQ;
• Kenvue in its pending $48.7 billion acquisition by Kimberly‑Clark;
• Fitch Learning, a subsidiary of Hearst, in its acquisition of Moody’s Analytics Learning Solutions and the Canadian Securities Institute;
• AngloGold Ashanti in its C$197 million acquisition of Augusta Gold and its corporate restructuring and change to domicile and primary listing location;
• Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL and its acquisition of SomaLogic;
• Costamare in the spin-off of Costamare Bulkers;
• Bridge Investment Group’s special committee in the $1.5 billion acquisition by Apollo;
• Light & Wonder in its $850 million acquisition of Grover Charitable Gaming, the $6.05 billion sale of SG Lottery to Brookfield and $1.2 billion sale of OpenBet to Endeavor, its acquisition of the remaining stake in SciPlay, the $925.5 million sale of a 34.9% stake to institutional investors and its $363.5 million carve-out IPO of SciPlay;
• FactSet in its $246.5 million acquisition of LiquidityBook and its acquisition of Irwin;
• Just Eat Takeaway.com in the sale of Grubhub to Wonder;
• Consolidated Communications’ special committee in the $3.1 billion acquisition by Searchlight and BCI;
• Hasbro in its $4 billion acquisition of Entertainment One (eOne), the sale of its eOne film and TV business to Lionsgate and the sale of eOne Music to Blackstone;
• BDT and its affiliates in connection with multiple transactions, including BDT’s combination with MSD Partners, the take‑private acquisition of Weber, valuing Weber at $3.7 billion, and its majority investment in Marquette Transportation;
• Owl Rock in Fifth Season Investments’ $220 million acquisition of Fifth Season Financial and the life insurance investment assets of Chapford Capital II and Chapford Diversified Strategies Fund;
• RWE in its $6.8 billion acquisition of the Con Edison Clean Energy Businesses; 
• SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
• White Mountains in the $1.775 billion sale of NSM to Carlyle, its $178 million majority investment in TRANZACT and the sale of TRANZACT to Clayton Dubilier & Rice and the $2.6 billion sale of Sirius International Insurance to China Minsheng Investment;
• CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
• GreenSky in its $2.24 billion acquisition by Goldman Sachs;
• Afterpay in its $29 billion acquisition by Block;
• Canadian National Railway in its proposed $33.6 billion combination with Kansas City Southern;
• National Grid in its £7.8 billion acquisition of Western Power Distribution and the $3.8 billion sale of Narragansett Electric;
• AerCap in its $30 billion acquisition of GE Capital Aviation Services;
• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;
• Time Warner in its $109 billion sale to AT&T;
• Northrop Grumman in the $3.4 billion sale of its federal IT and mission support business to Veritas Capital;
• Centrica in its $3.625 billion sale of Direct Energy to NRG Energy;
• Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
• Novartis in the $29.8 billion spin‑off of Alcon;
• US Foods in its $500 million convertible preferred equity investment from KKR and its $970 million acquisition of Smart Foodservice;
• Olin in its $5 billion tax-efficient Reverse Morris Trust merger with the chlorine value chain business of Dow Chemical;
• Peugeot in its $50 billion merger with Fiat Chrysler to form Stellantis;
• Viacom’s transaction committee in the $30 billion merger with CBS;
• WestRock in its $4.9 billion acquisition of KapStone;
• Starwood Hotels in its $13.3 billion sale to Marriott;
• British American Tobacco in its $97 billion acquisition of Reynolds American;
• Crown Castle in several transactions, including its $7.1 billion acquisition of Lightower; and
• Mylan in its $9.9 billion acquisition of Meda, its proposal to acquire Perrigo in a transaction valued at approximately $35 billion and its $750 million acquisition, through its Indian subsidiary Mylan Laboratories, of certain female healthcare businesses from Famy Care.

Mr. Bobby has been recognized for his work in the employee benefits and executive compensation arena by Chambers USA and he has also received Euromoney Legal Media Group’s 2022 Americas Rising Star Award for “Best in Labor & Employment.” Mr. Bobby is a frequent author and speaker on executive compensation and employee benefits topics and spoke on a panel at the American Bar Association’s 2023 Business Law Section Hybrid Spring Meeting.

Mr. Bobby was born in Pittsburgh, Pennsylvania. He received a B.A. summa cum laude in mathematics and physics and an M.A. in mathematics from the University of Pennsylvania in 2009, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2012, where he was an Executive Editor of the National Security Journal and the International Law Journal. Following his graduation, Mr. Bobby served as a law clerk to Hon. Joseph Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit.

Mr. Bobby joined Cravath in 2013 and was elected a partner in 2020.